Correlation Between Caribou Biosciences and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Neurocrine Biosciences, you can compare the effects of market volatilities on Caribou Biosciences and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Neurocrine Biosciences.
Diversification Opportunities for Caribou Biosciences and Neurocrine Biosciences
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Caribou and Neurocrine is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Neurocrine Biosciences
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Neurocrine Biosciences. In addition to that, Caribou Biosciences is 4.03 times more volatile than Neurocrine Biosciences. It trades about -0.17 of its total potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.3 per unit of volatility. If you would invest 13,305 in Neurocrine Biosciences on October 15, 2024 and sell it today you would earn a total of 785.00 from holding Neurocrine Biosciences or generate 5.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Caribou Biosciences vs. Neurocrine Biosciences
Performance |
| Timeline |
| Caribou Biosciences |
| Neurocrine Biosciences |
Caribou Biosciences and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Caribou Biosciences and Neurocrine Biosciences
The main advantage of trading using opposite Caribou Biosciences and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |